Jaguar Health, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.80 | -$1.80 | -$1.80 |
| Q2 2024 | 1 | -$1.20 | -$1.20 | -$1.20 |
| Q3 2024 | 1 | -$2.37 | -$2.37 | -$2.37 |
| Q4 2024 | 1 | -$1.67 | -$1.67 | -$1.67 |
| Q1 2025 | 1 | -$0.86 | -$0.86 | -$0.86 |
| Q2 2025 | 1 | -$0.75 | -$0.75 | -$0.75 |
| Q3 2025 | 1 | -$0.56 | -$0.56 | -$0.56 |
| Q4 2025 | 1 | -$0.50 | -$0.50 | -$0.50 |
| Q1 2026 | 1 | -$0.55 | -$0.55 | -$0.55 |
| Q2 2026 | 1 | -$0.57 | -$0.57 | -$0.57 |
| Q3 2026 | 1 | -$0.37 | -$0.37 | -$0.37 |
| Q4 2026 | 1 | -$0.35 | -$0.35 | -$0.35 |
Jaguar Health, Inc. Earnings Date And Information
Jaguar Health, Inc. last posted its earnings results on Wednesday, November 13th, 2024. The company reported $-1.05 earnings per share for the quarter, topping analysts' consensus estimates of $-2.37 by $1.32. The company had revenue of 3.07 M for the quarter and had revenue of 9.76 M for the year. Jaguar Health, Inc. has generated $-107 earnings per share over the last year ($-107.42 diluted earnings per share) and currently has a price-to-earnings ratio of -0.24. Jaguar Health, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 31st, 2025 based on prior year's report dates.
Jaguar Health, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$2.37 | -$1.05 | 1.32 | $3.90 M | $3.07 M |
| 08/13/2024 | Q2 2024 | -$1.20 | -$4.04 | -2.84 | $3.40 M | $2.72 M |
| 05/14/2024 | Q1 2024 | -$1.55 | -$3.48 | -1.93 | $2.35 M | |
| 04/01/2024 | Q4 2023 | -$0.40 | $2.30 M | |||
| 09/29/2023 | Q3 2023 | -$0.38 | $2.46 M | $2.81 M | ||
| 08/14/2023 | Q2 2023 | -$1.53 | -$0.69 | 0.84 | $2.28 M | $2.68 M |
| 05/15/2023 | Q1 2023 | -$2.39 | $1.97 M | |||
| 04/28/2023 | Q4 2022 | -$5.63 | $3.26 M | |||
| 11/14/2022 | Q3 2022 | -$5.62 | -$8.83 | -3.21 | $3.55 M | $3.15 M |
| 08/22/2022 | Q2 2022 | -$16.50 | -$8.77 | 7.73 | $3.10 M | $2.92 M |
| 05/10/2022 | Q1 2022 | -$12.75 | -$23.10 | -10.35 | $2.63 M | |
| 03/11/2022 | Q4 2021 | -$6.75 | -$23.41 | -16.66 | $2.08 M | |
| 11/17/2021 | Q3 2021 | -$12.75 | -$20.25 | -7.5 | $1.40 M | $630,000 |
| 08/13/2021 | Q2 2021 | -$3.00 | -$23.57 | -20.57 | $4.95 M | $385,000 |
| 05/17/2021 | Q1 2021 | -$1.50 | -$21.54 | -20.04 | $1.24 M | |
| 03/31/2021 | Q4 2020 | -$22.50 | -$51.06 | -28.56 | $2.58 M | |
| 11/16/2020 | Q3 2020 | -$8.25 | -$44.01 | -35.76 | $7.80 M | $2.77 M |
| 08/13/2020 | Q2 2020 | -$11.25 | -$87.00 | -75.75 | $6.20 M | $3.17 M |
| 05/14/2020 | Q1 2020 | -$17.25 | -$117.93 | -100.68 | $869,000 | |
| 04/02/2020 | Q4 2019 | -$270.05 | $1.51 M |
Jaguar Health, Inc. Earnings: Frequently Asked Questions
-
When is Jaguar Health, Inc.'s earnings date?
Jaguar Health, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 31st, 2025 based off last year's report dates.
-
Did Jaguar Health, Inc. beat their earnings estimates last quarter?
In the previous quarter, Jaguar Health, Inc. (:JAGX) reported $-1.05 earnings per share (EPS) to beat the analysts' consensus estimate of $-2.37 by $1.32.
-
How can I listen to Jaguar Health, Inc.'s earnings conference call?
The conference call for Jaguar Health, Inc.'s latest earnings report can be listened to online.
-
How can I read Jaguar Health, Inc.'s conference call transcript?
The conference call transcript for Jaguar Health, Inc.'s latest earnings report can be read online.
-
How much revenue does Jaguar Health, Inc. generate each year?
Jaguar Health, Inc. (:JAGX) has a recorded annual revenue of $9.76 M.
-
How much profit does Jaguar Health, Inc. generate each year?
Jaguar Health, Inc. (:JAGX) has a recorded net income of $9.76 M. Jaguar Health, Inc. has generated $-107.42 earnings per share over the last four quarters.
-
What is Jaguar Health, Inc.'s price-to-earnings ratio?
Jaguar Health, Inc. (:JAGX) has a price-to-earnings ratio of -0.24 and price/earnings-to-growth ratio is 0.03.
